投資評等
最後更新日期：2025/1/3
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/11/5 | Imperial Capital | In-line >> Outperform | $27 >> $27 |
| 2007/8/16 | Matrix Research | Hold Buy | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/4/16 | Imperial Capital | Outperform >> In-line | $38 >> $27 |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2009/1/16 | Oppenheimer | Outperform | 32 |
| 2005/6/24 | Jefferies Co | Hold | |
| 2004/3/30 | UBS | Neutral | 27 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2013/5/2 | Imperial Capital | Outperform | 31 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2011/4/28 | Oppenheimer | Outperform | $33 >> $37 |
| 2008/11/19 | Friedman Billings | Outperform | |
| 2006/12/15 | Friedman Billings | Outperform | |
| 2006/5/8 | Jefferies & Co | Hold | |
| 2006/5/4 | Friedman Billings | Outperform | |
| 2004/12/17 | UBS | Neutral | 37 |
| 2003/8/1 | Lehman Brothers | Overweight | 21 |